Amarin Corp Plc (AMRN)

[FlyFishingStocks]

We've been indoctrinated to believe EPA is superior to EPA + DHA because of the diminished rise in LDL. But JL has effectively explained, using the JELIS study, that despite the rise in LDL ("fuel"), EPA nullifies the ill effects by lowering the "thermostatic" membrane receptors, preventing oxidation -> inflammation.
This question came to mind: If, as pointed out in Zu's post today, DHA has therapeutic effects, then could Lovaza and Generic Lovaza use this evidence to claim superiority? Could they piggy-back on the R-IT results and rob a chunk of V's market?

(sorry just read post #82644 after I posted this. I think Zumantu just answered this in his response to Marzan)